
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings Inc. is projected to achieve total revenues of $890 million in 2026, reflecting a significant 17% increase over preliminary 2025 revenues, indicating robust growth prospects. Key performance metrics, such as a 26% growth rate in new surgeon adoption and a 30% increase in established territory revenue, contribute to a strong overall surgical volume increase of 28% year-over-year for the second consecutive quarter. Additionally, the company's adjusted EBITDA reached $26 million, surpassing expectations and demonstrating the potential for improved margins and positive free cash flow durability, bolstering a favorable outlook for the company.
Bears say
Alphatec Holdings Inc.'s financial outlook appears negative due to concerns regarding lower-than-expected revenue growth in the U.S. market, along with reduced free cash flow projections, indicating a potential slowdown in financial performance. Despite reporting total revenues between $763M and $764M, slightly exceeding previous guidance, sequential growth in surgical sales has shown signs of deceleration, which may add downward pressure on the stock. Additionally, risks such as increased competition, disrupted procedure volumes from the COVID-19 pandemic, and potential future legal issues further contribute to the bearish sentiment surrounding the company's prospects.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares